Abstract
The interest in the development of nanoparticles for diverse applications, mainly biomedical and technological purposes, has been greatly increasing in recent years. Among the nanostructured materials, metallic nanoparticles, in particular, iron oxide magnetic nanoparticles have been the focus of intensive research. Recently, the biomedical applications of iron oxide magnetic nanoparticles, such as magnetite (Fe3O4) and maghemite (γ-Fe2O3), have been increasing. Due to their special properties, such as small sizes and superparamagnetic behavior at room temperature, these nanoparticles find important pharmacological applications, such as drug delivery and contrast agents in magnetic resonance imaging. Iron oxide nanoparticles, with different sizes and coating surfaces, can be synthesized by well-established physical, chemical, and, more recent, biogenic techniques. Biogenic synthesis of iron oxide nanoparticles has emerged as a new and environment-friendly approach to obtain biocompatible nanomaterials. It must be noted that, for biomedical or technological applications of iron oxide nanoparticles, it is of paramount importance to fully characterize the in vitro and in vivo toxicity of these nanoparticles. In recent years, important studies have been characterized the cyto- and genotoxicity, as well as the biological consequences due to in vivo administration of iron oxide nanoparticles. In despite of these advances in toxicological evaluations of these nanoparticles, there are still some important questions to be answered. For biomedical or technological applications, it is mandatory to characterize in details the toxicity of this nanomaterial, as well as its fate upon in vivo administration. In this regard, this chapter summarizes the recent progress in the synthesis of iron oxide nanoparticles and the in vitro and in vivo characterization of nanoparticle toxicities.
The present chapter highlights the drawbacks and challenges that still need to be overcome regarding the toxicity of iron oxide nanoparticles, in order to propose their safe use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abad JM, Mertens SFL, Pita M et al (2005) Functionalization of thioctic acid-capped gold nanoparticles for specific immobilization of histidine-tagged proteins. J Am Chem Soc 127:5689–5694
Andjelkovic M, Van Camp J, de Meulenaer B et al (2006) Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chem 98:23–31
Asuhan S, Wan HL, Zhao S et al (2012) Water-soluble, mesoporous Fe3O4: synthesis, characterization, and properties. Ceram Int 38:6579–6584
Auffan M, Decome L, Rose J et al (2006) In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: a physicochemical and cyto-genotoxical study. Environ Sci Technol 40:4367–4373
Batlle X, Labarta A (2002) Finite-size effects in fine particles: magnetic and transport properties. J Phys D Appl Phys 35:R15–R42
Becuwe M, Rouge P, Gervais C et al (2012) A new sensitive organic/inorganic hybrid material based on titanium oxide for the potentiometric detection of iron(III). J Colloid Interface Sci 88:130–136
Bharde A, Rautaray D, Bansal V et al (2006) Extracellular biosynthesis of magnetite using fungi. Small 2:135–141
Bryne JM, Telling ND, Coker VS et al (2011) Control of nanoparticle size, reactivity and magnetic properties during the bioproduction of magnetite by Geobacter sulfurreducens. Nanotechnology 22(45):455709. doi:10.1088/0957-4484/22/45/455709
Chakka VM, Altuncevahir B, Jin ZQ et al (2006) Magnetic nanoparticles produced by surfactant-assisted ball milling. J Appl Phys 99:08E912–08E915
Chen D, Xu R (1998) Hydrothermal synthesis and characterization of nanocrystalline Fe3O4 powders. Mater Res Bull 33:1015–1021
Chien CL (1991) Granular magnetic solids. J Appl Phys 69:5267–5272
Doak SH, Griffiths SM, Manshian B (2009) Confounding experimental considerations in nanogenotoxicology. Mutagenesis 24:285–293
Durán N, Seabra AB (2012) Metallic oxide nanoparticles: state of the art in biogenic syntheses and their mechanisms. Appl Microbiol Biotechnol 95:275–288
Gudadhe J, Bonde SR, Gaikwad SC et al (2011) Phoma glomerata: a novel agent for fabrication of iron oxide nanoparticles. J Bionanosci 5:138–142
Guichard Y, Schmit J, Darne C (2012) Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells. Ann Occup Hyg 56:631–644
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021
Haddad PS, Seabra AB (2012) Biomedical applications of magnetic nanoparticles. In: Martinez AI (ed) Iron oxides: structure, properties and applications. Nova, Nova York, pp 165–188
Haddad PS, Duarte EL, Baptista MS et al (2004) Synthesis and characterization of silica-coated magnetic nanoparticles. Prog Colloid Polym Sci 128:232–238
Haddad PS, Rocha TR, Souza EA et al (2009) Interplay between crystallization and particle growth during the isothermal annealing of colloidal iron oxide nanoparticles. J Colloid Interface Sci 339:344–350
Herrera-Becerra R, Rius JL, Zorrilla C (2010) Tannin biosynthesis of iron oxide nanoparticles. Appl Phys A 100:453–459
Hong SC, Lee JH, Lee J et al (2011) Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomedicine 6:3219–3231
Hoskins C, Cuschieri A, Wang L (2012) Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application. J Nanobiotechnology 10:15. http://www.jnanobiotechnology.com/content/10/1/15
Jain TK, Reddy MK, Morales MA (2008) Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 5:316–327
Jiang WQ, Yang HC, Yang SY et al (2004) Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J Magn Magn Mater 283:210–214
Jun WK, Willens RH, Duwez P (1960) Non-crystalline structure in solidified gold–silicon alloys. Nature 187:869–870
Jung H, Kim JW, Choi H et al (2008) Synthesis of nanosized biogenic magnetite and comparison of its catalytic activity in ozonation. Appl Catal B: Environ 83:208–213
Khollam YB, Dhage SR, Potdar HS et al (2002) Microwave hydrothermal preparation of submicron-sized spherical magnetite (Fe3O4) powders. Mater Lett 56:571–577
Konczol M, Ebeing S, Goldenberg E et al (2011) Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-kappa B. Chem Res Toxicol 24:1460–1475
Krumov N, Perner-Nochta I, Oder S et al (2009) Production of inorganic nanoparticles by microorganisms. Chem Eng Technol 32:1026–1035
Kucheryavy P, He J, John VT et al (2013) Superparamagnetic iron oxide nanoparticles with variable size and an iron oxidation state as prospective imaging agents. Langmuir 29:710–716
Kwon JT, Hwang SK, Jin H et al (2008) Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health 50:1–6
LaMer VK, Dinegar RH (1950) Theory, production and mechanism of formation of monodispersed hydrosols. J Am Chem Soc 72:4847–4854
Laurent S, Forge D, Port M et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110
Li Y-F, Chen C (2011) Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small 7:2965–2980
Li X, Xu H, Chen ZS et al (2011) Biosynthesis of nanoparticles by microorganisms and their applications. J Nanomater Art. ID 270974. doi:10.1155/2011/270974
Lien Y-H, Wu T-M, Wu J-H et al (2011) Cytotoxicity and drug release behavior of PNIPAM grafted on silica-coated drug release behavior grafted on silica-coated iron oxide nanoparticles. J Nanopart Res 13:5065–5075
Lima JE, de Biasi E, Vasquez MM et al (2010) Surface effects in the magnetic properties of crystalline 3 nm ferrite nanoparticles chemically synthesized. J Appl Phys 108:103919–103929
Lin SY, Chen NT, Sum SP et al (2008) Ligand exchanged photoluminescent gold quantum dots functionalized with leading peptides for nuclear targeting and intracellular imaging. Chem Commun 39:4762–4764
Lübbe AS, Bergemann C, Riess H et al (1996a) Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 56:4694–4701
Lübbe AS, Bergemann C, Riess H et al (1996b) Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56:4686–4693
Ma H-L, Qi X-R, Ding W-X (2008) Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. J Biomed Mater Res 84A:598–606
Mahmoudi M, Hofmann H, Rothen-Rutishauser B et al (2012) Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev 112:2323–2338
Maleki H, Simchi A, Imani M et al (2012) Size-controlled synthesis of superparamagnetic iron oxide nanoparticles and their surface coating by gold for biomedical applications. J Magn Magn Mater 324:3997–4005
Marchiol L (2012) Synthesis of metal nanoparticles in living. Italian J Agron 7:274–282
Molina MM, Seabra AB, de Oliveira MG et al (2013) Nitric oxide donor superparamagnetic iron oxide nanoparticles. Mat Sci Eng C 33:746–751
Munnier E, Cohen-Jonathan S, Herve K et al (2011) Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity. J Nanopart Res 13:959–971
Nguyen DP, Trinh XS, Hoang TC et al (2012) Amorphous iron-chromium oxide nanoparticles prepared by sonochemistry. J Non-Cryst Solids 358:537–543
Park S, Lee H, Goo S et al (2011) Composition behavior of carbon nanotube reinforced thermotropic liquid crystalline polymers. J Appl Polym Sci 122:2060–2070
Rai M, Durán N (eds) (2011) Metal nanoparticles in microbiology, 1st edn. Springer, Germany
Ranade VV, Hollinger MA (eds) (2004) Drug delivery systems. Pharmacology and toxicology: basic and clinical aspects, 2nd edn. New York, CRC Press
Rutledge RD, Warner CL, Pittman JW et al (2010) Thiol-ene induced diphosphonic acid functionalization of superparamagnetic iron oxide nanoparticles. Langmuir 26:12285–12292
Schweiger C, Pietzonka C, Heverhagen J (2011) Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging. Int J Pharm 408:130–137
Shopska M, Cherkezova-Zheleva ZP, Paneva DG et al (2013) Biogenic iron compounds: XRD, Mossbauer and FTIR study. Cent Eur J Chem 11:215–227
Singh SP, Chakradhar RPS, Rao JL et al (2010) EPR, FTIR, optical absorption and photoluminescence studies of Fe2O3 and CeO2 doped ZnO-Bi2O3-B2O3 glasses. J Alloys Compd 493:56–262
Singh AP, Mettenborger A, Golus P et al (2012) Photoelectrochemical properties of hematite films grown by plasma enhanced chemical vapor deposition. Int J Hydrogen Energ 37:13983–13988
Souza EA, Winnischofer H, Haddad P et al (2009) Effects of particles size and synthesis temperature on the structural properties of the Ni nanoparticles: insights about the formation of the fcc-Ni structure. AIP Conf Proc 1092:135–137
Tsai ZT, Tsai FY, Yang WC et al (2012) Preparation and characterization of ferrofluid stabilized with biocompatible chitosan and dextran sulfate hybrid biopolymer as a potential magnetic resonance imaging (MRI) T2 contrast agent. Mar Drugs 10:2403–2414
Wahajuddin AS (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine 7:3445–3471
Wang Z, Li X, Gao M et al (2012) One-step preparation of amorphous iron nanoparticles by laser ablation. Powder Technol 215:147–150
Weissleder R, Stark DD, Engelstad BL et al (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152:167–173
Willard MA, Kurihara LK, Carpenter EE et al (2004) Chemically prepared magnetic nanoparticles. Int Mat Rev 49:125–170
Ying E, Hwang H-M (2010) In vitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 408:4475–4481
Zhou Z, Huang D, Bao J et al (2012) A synergistically enhanced T1–T2 dual-modal contrast agent. Adv Mater 24:6223–6228
Zhu M-T, Feng W-Y, Wang B et al (2008) Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology 247:102–111
Zhu J, Wei S, Gu H et al (2012) One-pot synthesis of magnetic graphene nanocomposites decorated with core@double-shell nanoparticles for fast chromium removal. Environ Sci Technol 46:977–985
Acknowledgements
FAPESP, CNPq, CAPES, INOMAT (MCT/CNPq), and Brazilian Network in Nanotoxicology (MCT-CNPq).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Seabra, A.B., Haddad, P.S. (2014). Cytotoxicity and Genotoxicity of Iron Oxides Nanoparticles. In: Durán, N., Guterres, S., Alves, O. (eds) Nanotoxicology. Nanomedicine and Nanotoxicology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8993-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8993-1_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8992-4
Online ISBN: 978-1-4614-8993-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)